Zobrazeno 1 - 2
of 2
pro vyhledávání: '"D. B. Goltyapin"'
Autor:
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 5, Pp 551-556 (2015)
Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including dabigatran etexilate, in the stroke prevention in patients with atrial fibrillation are considered. Factors that influence the choice of dabigatran dose
Externí odkaz:
https://doaj.org/article/5cc44adbbae74f068d1d2dfd33f7451a
Autor:
S. G. Kanorskiy, A. A. Kastanayan, E. D. Kosmacheva, M. E. Statsenko, N. V. Haylo, E. A. Lipnitskaya, D. B. Goltyapin
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 9, Iss 5, Pp 551-556 (2015)
Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including dabigatran etexilate, in the stroke prevention in patients with atrial fibrillation are considered. Factors that influence the choice of dabigatran dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4e2198a1777b451e1aa92cd8686dcd
http://www.rpcardio.ru/jour/article/view/232
http://www.rpcardio.ru/jour/article/view/232